Search Results - "Silva Costa, F."

Refine Results
  1. 1
  2. 2
  3. 3

    Uterine fibroids and non‐informative cell‐free DNA screening results by Rolnik, D. L., Raymond, Y., Lee, T., Ramkrishna, J., Silva Costa, F., Menezes, M., Meagher, S.

    Published in Ultrasound in obstetrics & gynecology (01-10-2024)
    “…ABSTRACT Objective Uterine fibroids are monoclonal tumors, which are often genetically abnormal and associated with false‐positive genome‐wide cell‐free DNA…”
    Get full text
    Journal Article
  4. 4

    Definitions matter: detection rates and perinatal outcome for infants classified prenatally as having late fetal growth restriction using SMFM biometric vs ISUOG/Delphi consensus criteria by Schreiber, V., Hurst, C., Silva Costa, F., Stoke, R., Turner, J., Kumar, S.

    Published in Ultrasound in obstetrics & gynecology (01-03-2023)
    “…Objectives Fetal growth restriction (FGR) is often secondary to placental dysfunction and is suspected prenatally based on biometric or circulatory…”
    Get full text
    Journal Article
  5. 5

    Implications of failure to achieve a result from prenatal maternal serum cell‐free DNA testing: a historical cohort study by Chan, N, Smet, M‐E, Sandow, R, Silva Costa, F, McLennan, A

    “…Objective To investigate the pregnancy outcomes in a cohort of women who failed to obtain a result in non‐invasive prenatal testing (NIPT). Design Historical…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    ISUOG Practice Guidelines: ultrasound assessment of fetal biometry and growth by Salomon, L.J., Alfirevic, Z., Da Silva Costa, F., Deter, R.L., Figueras, F., Ghi, T., Glanc, P., Khalil, A., Lee, W., Napolitano, R., Papageorghiou, A., Sotiradis, A., Stirnemann, J., Toi, A., Yeo, G.

    Published in Ultrasound in obstetrics & gynecology (01-06-2019)
    “…Pautas de ISUOG para la práctica: evaluación ecográfica de la biometría y el crecimiento fetal INTRODUCCIÓN El objetivo de estas Pautas es describir la…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16

    ISUOG Practice Guidelines: role of ultrasound in screening for and follow‐up of pre‐eclampsia by Sotiriadis, A., Hernandez‐Andrade, E., da Silva Costa, F., Ghi, T., Glanc, P., Khalil, A., Martins, W.P., Odibo, A.O., Papageorghiou, A.T., Salomon, L.J., Thilaganathan, B.

    Published in Ultrasound in obstetrics & gynecology (01-01-2019)
    “…RESUMEN Pautas de práctica de ISUOG: la función del ultrasonido en la detección y seguimiento de la preeclampsia Introducción La hipertensión en el embarazo…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Association between fetal fraction on cell‐free DNA testing and first‐trimester markers for pre‐eclampsia by Rolnik, D. L., da Silva Costa, F., Lee, T. J., Schmid, M., McLennan, A. C.

    Published in Ultrasound in obstetrics & gynecology (01-12-2018)
    “…ABSTRACT Objectives To evaluate the association between fetal fraction on cell‐free DNA (cfDNA) testing and first‐trimester markers for pre‐eclampsia, and to…”
    Get full text
    Journal Article
  19. 19

    Placental growth factor and fetoplacental Doppler indices in combination predict preterm birth reliably in pregnancies complicated by fetal growth restriction by Hong, J., Crawford, K., Cavanagh, E., da Silva Costa, F., Kumar, S.

    Published in Ultrasound in obstetrics & gynecology (01-05-2024)
    “…ABSTRACT Objective To assess the association between placental biomarkers (placental growth factor (PlGF) and soluble fms‐like tyrosine kinase‐1 (sFlt‐1)/PlGF…”
    Get full text
    Journal Article
  20. 20